Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine)

Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21

(2022) Haidong Wang et al.   LANCET

Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines

(2022) Janos Szebeni et al.   Nature Nanotechnology

SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals

(2022) Alessandra Ruggiero et al.   EBioMedicine

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine

(2022) Yi Ju et al.   ACS Nano

Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration

(2022) Giuditta Guerrini et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

(2022) Oliver J Watson et al.   LANCET INFECTIOUS DISEASES

Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel

(2022) Emilia Anis et al.   Journal of Allergy and Clinical Immunology-In Practice

mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations

(2022) Juan Manuel Carreño et al.   VACCINE

Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies

(2021) Bing-Mae Chen et al.   ACS Nano

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination

(2021) Xin Rong Lim et al.   Vaccines

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement

(2021) Mariona Estapé Senti et al.   JOURNAL OF CONTROLLED RELEASE

Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex

(2020) Even Chen et al.   ACS Nano

Antibody responses to SARS-CoV-2 in patients with COVID-19

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro

(2018) Barry Neun et al.   MOLECULES

Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

(2017) Yu-Cheng Su et al.   Nature Communications

Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population

(2016) Qi Yang et al.   ANALYTICAL CHEMISTRY

Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals

(2016) Bing-Mae Chen et al.   ANALYTICAL CHEMISTRY

The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?

(2016) Christian Lubich et al.   PHARMACEUTICAL RESEARCH

Anti-PEG immunity: emergence, characteristics, and unaddressed questions

(2015) Qi Yang et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases

(2015) Keren Turjeman et al.   PLoS One

Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

(2014) Michael S Hershfield et al.   ARTHRITIS RESEARCH & THERAPY

Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles

(2013) Barbara L Mui et al.   Molecular Therapy-Nucleic Acids

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents

(2012) Ricardo P Garay et al.   Expert Opinion on Drug Delivery

Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome

(2011) János Szebeni et al.   Nanomedicine-Nanotechnology Biology and Medicine

Sensitive Quantification of PEGylated Compounds by Second-Generation Anti-Poly(ethylene glycol) Monoclonal Antibodies

(2010) Yu-Cheng Su et al.   BIOCONJUGATE CHEMISTRY

307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON

(2010) H. Tillmann et al.   JOURNAL OF HEPATOLOGY